Invivyd (IVVD) director Tamsin Berry receives stock options for 50,000 shares

Rhea-AI Filing Summary

Invivyd, Inc. director Tamsin Berry received a compensation-related stock option grant covering 50,000 shares of common stock. The option has an exercise price of $1.0400 per share and expires on May 18, 2036. It vests in full on the earlier of May 19, 2027 or the company’s 2027 Annual Meeting of Stockholders, subject to her continuous service through the vesting date. Following this grant, she holds stock options for 50,000 shares directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Berry Tamsin

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	50,000	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 50,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Option grant size: 50,000 shares Exercise price: $1.0400 per share Expiration date: May 18, 2036 +2 more

5 metrics

Option grant size 50,000 shares Stock Option (Right to Buy) granted to director

Exercise price $1.0400 per share Stock option strike price

Expiration date May 18, 2036 Option term end

Vesting date Earlier of May 19, 2027 or 2027 Annual Meeting Full vesting trigger, subject to continuous service

Holdings after grant 50,000 options Total derivative securities following transaction

Key Terms

Stock Option (Right to Buy), exercise price, vests in full, Annual Meeting of Stockholders, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

exercise price financial

"conversion_or_exercise_price: "1.0400""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vests in full financial

"This option was granted on May 19, 2026 and vests in full upon the earlier"

Annual Meeting of Stockholders financial

"the date of the Issuer's 2027 Annual Meeting of Stockholders"

continuous service financial

"subject to the Reporting Person's continuous service through such vesting date"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Berry Tamsin

(Last) (First) (Middle)

C/O INVIVYD, INC.

209 CHURCH STREET

(Street)

NEW HAVEN CONNECTICUT 06510

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Invivyd, Inc. [ IVVD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.04	05/19/2026		A		50,000		(1)	05/18/2036	Common Stock	50,000	$0	50,000	D

Explanation of Responses:

1. This option was granted on May 19, 2026 and vests in full upon the earlier of (i) May 19, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.

Remarks:

Exhibit 24.1: Power of Attorney

	/s/ Jill Andersen attorney-in-fact for Tamsin Berry	05/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Invivyd (IVVD) director Tamsin Berry report in this Form 4?

She reported receiving a stock option grant for 50,000 shares of Invivyd common stock. The award is a compensation grant, not an open-market purchase, and gives her the right to buy shares at a fixed exercise price in the future.

What are the key terms of Tamsin Berry’s Invivyd (IVVD) stock option grant?

The option covers 50,000 shares of common stock at an exercise price of $1.0400 per share. It expires on May 18, 2036 and represents a right to buy shares, rather than an immediate stock purchase.

When do the Invivyd (IVVD) options granted to Tamsin Berry vest?

The options vest in full on the earlier of May 19, 2027 or the date of Invivyd’s 2027 Annual Meeting of Stockholders. Vesting is conditioned on her continuous service with the company through the applicable vesting date.

Is Tamsin Berry’s Invivyd (IVVD) Form 4 transaction a stock sale or purchase?

The transaction reflects an option grant classified as an acquisition, not an open-market stock sale or purchase. It is a compensation award giving her future purchase rights rather than an immediate cash transaction in Invivyd shares.

How many Invivyd (IVVD) derivative securities does Tamsin Berry hold after this grant?

After the reported transaction, she holds stock options covering 50,000 shares of Invivyd common stock directly. This figure reflects her total derivative holdings reported in this Form 4 following the new grant.